LOGIN  |  REGISTER
Cue Biopharma

LifeBridge Health selects NRC Health as its new patient experience partner

August 29, 2023 | Last Trade: US$17.76 0.08 -0.45

LINCOLN, Neb., Aug. 29, 2023 (GLOBE NEWSWIRE) -- LifeBridge Health has selected NRC Health to be its partner in providing Human Understanding® through personalized healthcare solutions and data-driven insights.

LifeBridge Health is one of the largest, most comprehensive health systems in Maryland and includes Sinai Hospital, Northwest Hospital, Carroll Hospital, Levindale Hebrew Geriatric Center and Hospital, Grace Medical Center and related subsidiaries and affiliates.

“We’re excited to welcome LifeBridge Health to the NRC Health family and are looking forward to building a long-term relationship,” said Helen Hrdy, Chief Growth Officer at NRC Health. “Both of our teams believe in delivering innovative and high-quality care that is centered on improving the patient experience and overall health through a human-centered approach.”

LifeBridge Health will implement NRC Health’s end-to-end Human Understanding program which supports the nation’s leading healthcare organizations in delivering holistic, innovative, and leading-edge solutions, programs, and metrics to better support patients and care teams. These solutions help elevate humanized care, enhance the health care experience, and improve outcomes for patients and providers alike.

This partnership also includes administering the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey, an additional quality measure that underscores LifeBridge Health’s commitment to its patients and their families. 

About NRC Health

For more than 40 years, NRC Health (NASDAQ: NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health’s commitment to Human Understanding® helps leading healthcare systems get to know each person they serve not as point-in-time insights, but as an ongoing relationship. Guided by its uniquely empathic heritage, NRC Health’s patient-focused approach, unmatched market research, and emphasis on consumer preferences are transforming the healthcare experience, creating strong outcomes for patients and entire healthcare systems. NRC Health is ranked #1 for Patient Experience Improvement in the 2023 Best in KLAS report.

For more information, please email This email address is being protected from spambots. You need JavaScript enabled to view it., or visit www.nrchealth.com.

Media Contact:                                                                        
Stephanie Schultz                                 
This email address is being protected from spambots. You need JavaScript enabled to view it.
262-370-1100 

Astria Therapeutics

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB